Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by Atria Investments Inc

Atria Investments Inc lessened its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 3.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 26,176 shares of the company’s stock after selling 948 shares during the period. Atria Investments Inc’s holdings in Pediatrix Medical Group were worth $343,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Pacer Advisors Inc. acquired a new position in shares of Pediatrix Medical Group during the fourth quarter worth $35,492,000. Weiss Asset Management LP boosted its position in shares of Pediatrix Medical Group by 50.5% during the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock worth $10,580,000 after acquiring an additional 306,143 shares in the last quarter. RBF Capital LLC purchased a new position in shares of Pediatrix Medical Group in the 3rd quarter valued at about $1,695,000. Rubric Capital Management LP raised its position in shares of Pediatrix Medical Group by 1.5% during the 3rd quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company’s stock worth $95,907,000 after acquiring an additional 125,000 shares in the last quarter. Finally, Algert Global LLC purchased a new stake in Pediatrix Medical Group during the third quarter worth approximately $1,315,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Mizuho raised their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Tuesday, November 19th. Truist Financial boosted their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Macquarie assumed coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective on the stock. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Finally, UBS Group raised their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $13.71 on Monday. The stock’s 50-day moving average price is $14.16 and its 200 day moving average price is $13.43. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $1.18 billion, a PE ratio of -11.42, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. As a group, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.